MAP2K1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Products
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1), 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4E4 (formerly 4E4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3B4 (formerly 3B4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1E5 (formerly 1E5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI2E8 (formerly 2E8)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 mouse monoclonal antibody, clone OTI9E9 (formerly 9E9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI5A11 (formerly 5A11)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI3C1 (formerly 3C1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Recombinant protein of human mitogen-activated protein kinase kinase 1 (MAP2K1 mutant D67N), with C-terminal MYC/DDK tag, expressed in human cells, 20ug
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Pathways
- Acute myeloid leukemia (262)
- B cell receptor signaling pathway (262)
- Bladder cancer (262)
- Chemokine signaling pathway (262)
- Chronic myeloid leukemia (262)
- Colorectal cancer (262)
- Dorso-ventral axis formation (262)
- Endometrial cancer (262)
- ErbB signaling pathway (262)
- Fc epsilon RI signaling pathway (262)
- Fc gamma R-mediated phagocytosis (262)
- Focal adhesion (262)
- Gap junction (262)
- Glioma (262)
- GnRH signaling pathway (262)
- Insulin signaling pathway (262)
- Long-term depression (262)
- Long-term potentiation (262)
- MAPK signaling pathway (262)
- Melanogenesis (262)
- Melanoma (262)
- Natural killer cell mediated cytotoxicity (262)
- Neurotrophin signaling pathway (262)
- Non-small cell lung cancer (262)
- Oocyte meiosis (262)
- Pancreatic cancer (262)
- Pathways in cancer (262)
- Prion diseases (262)
- Progesterone-mediated oocyte maturation (262)
- Prostate cancer (262)
- Regulation of actin cytoskeleton (262)
- Renal cell carcinoma (262)
- T cell receptor signaling pathway (262)
- Thyroid cancer (262)
- Toll-like receptor signaling pathway (262)
- VEGF signaling pathway (262)
- Vascular smooth muscle contraction (262)
